XML 61 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income (Loss) Before Income Taxes
For financial reporting purposes, income before income taxes includes the following components:

Years Ended December 31,
(in millions)202220212020
United States$8.5 $12.8 $40.9 
Foreign(4.1)1.0 3.6 
Income before income taxes$4.4 $13.8 $44.5 
Provision (Benefit) for Income Tax
The provision (benefit) for income taxes consists of the following:

Years Ended December 31,
(in millions)202220212020
Current provision (benefit):
Federal$17.4 $(0.4)$(14.2)
State2.4 (0.7)2.3 
Foreign2.3 0.3 1.8 
Total current provision (benefit)
22.1 (0.8)(10.1)
Deferred (benefit) provision:
Federal(18.3)(0.1)12.3 
State(1.0)1.1 (1.4)
Foreign2.2 (2.3)(2.3)
Total deferred (benefit) provision
(17.1)(1.3)8.6 
Total provision (benefit):
Federal(0.9)(0.5)(1.9)
State1.4 0.4 0.9 
Foreign4.5 (2.0)(0.5)
Total income tax provision (benefit)
$5.0 $(2.1)$(1.5)
Reconciliation of Provision for Income Taxes at Statutory Federal Income Tax Rate A reconciliation of the provision (benefit) for income taxes at the statutory federal income tax rate to the amount provided is as follows:
Years Ended December 31,
(in millions)202220212020
Tax expense at the statutory federal income tax rate$0.9 $2.9 $9.3 
State income tax, net of federal income tax0.6 1.3 0.3 
Research and development tax credits(3.3)(4.1)(4.3)
FIN 48 impact1.2 1.8 4.0 
FIN 48 impact - liquidation of subsidiary— (0.7)— 
Change in foreign subsidiary net operating loss carryforward— 4.4 (0.3)
Valuation allowance impact6.0 (8.1)(1.0)
Changes in tax rates0.2 0.7 0.3 
Effects of Cares Act - 2018 NOL carryback— — (9.5)
Share-based compensation0.4 0.4 0.3 
Foreign-derived intangible income deduction(0.9)— — 
Other items(0.1)(0.7)(0.6)
Total income tax provision (benefit)$5.0 $(2.1)$(1.5)
Significant Components of Company's Deferred Tax Assets and Liabilities
Significant components of the Company's deferred tax assets and liabilities are as follows:

December 31,
(in millions)20222021
Deferred tax assets:
Amortization of research and experimental expenditures$18.4 $— 
Inventory reserves4.7 3.7 
Warranty reserves2.2 2.0 
Credit loss reserves0.6 0.5 
State tax loss carryforwards11.6 11.9 
Accrued vacation1.6 1.4 
Deferred compensation1.1 1.4 
Share-based compensation4.4 2.0 
Goodwill1.8 2.0 
Foreign net operating loss7.2 4.4 
Lease obligation1.8 0.4 
Employee & insurance accruals1.0 0.8 
Domestic credit carryforwards1.5 1.5 
Deferred revenue1.7 1.3 
Deferred payroll tax - CARES Act— 1.1 
Valuation allowances(11.9)(5.9)
Other0.9 1.5 
Total deferred tax assets48.6 30.0 
Deferred tax liabilities:
Property and equipment13.6 13.0 
Intangibles2.7 1.1 
Right-of-use assets1.8 0.5 
Post-retirement benefits0.5 0.6 
Total deferred tax liabilities18.6 15.2 
Total net deferred assets$30.0 $14.8 
Rollforward of Deferred Tax Assets Valuation Allowance
The following table represents a rollforward of the deferred tax asset valuation allowance for the years ended December 31, 2022, 2021 and 2020:

Years Ended December 31,
(in millions)202220212020
Allowance balance, beginning of year$5.9 $14.0 $14.6 
Provision6.0 0.6 1.5 
Reversals— (8.1)(1.5)
Other— (0.6)(0.6)
Allowance balance, end of year$11.9 $5.9 $14.0 
Reconciliation of Unrecognized Tax Benefit
A reconciliation of the beginning and ending unrecognized tax benefits excluding interest and penalties is as follows:

Years Ended December 31,
(in millions)202220212020
Balance, beginning of year$10.8 $9.7 $5.7 
Additions for tax positions taken in current year1.2 1.0 0.5 
Additions for tax positions taken in prior period— 0.8 3.5 
Decreases related to sustained tax positions— (0.7)— 
Balance, end of year$12.0 $10.8 $9.7